The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 31 October 2006, www.theannals.com, DOI 10.1345/aph.1H379.
 The Annals of Pharmacotherapy: Vol. 40, No. 12, pp. 2248-2250. DOI 10.1345/aph.1H379
© 2006 Harvey Whitney Books Company.
This Article
Right arrow Abstract Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by White, C M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, C M.

Bien que des essais cliniques aient prouvé que l'utilisation de certains médicaments cardiovasculaires améliorent la morbidité et la mortalité, ils ne sont pas largement utilisés, sont globalement prescrits à posologies insuffisantes, et voient, de plus, leur bénéfice encore diminué par la non compliance. Les pharmaciens ont la capacité d'améliorer la survie de ces patients. A cet effet, un effort doit être fait du côté de chaque pharmacien et du développement de services du système de santé. Nous devons agir sur l'amélioration de l'accès des patients, leur prise en charge, et la connaissance des échéances de renouvellement de délivrances pour améliorer le niveau de soins. Nous devons soutenir et développer davantage les consultations pharmaceutiques dans l'anticoagulation, l'hyperlipidémie, et l'hypertension.

Michel Le Duff

www.theannals.com, DOI 10.1345/aph.1H379


This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
K. Lertsburapa, C. M. White, J. Kluger, O. Faheem, J. Hammond, and C. I. Coleman
Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery.
J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 405 - 411.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by White, C M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, C M.

homecopy help contact us subscription past issues search current issue
Copyright © 2006 by Harvey Whitney Books Company.